Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Prof. Colin Berry
Dr. Bernard De Bruyne
By Colin Berry, (Glasgow, United Kingdom)View Discussant report
Read the press releaseOpen the PresentationWatch the WebcastESC TV: Watch Professor Berry's interview
List of Authors:
Dr Jamie Layland 1,2 PhD, Professor Keith Oldroyd 1 MD (Hons), Professor Nick Curzen 3 BM(Hons) PhD, Dr Arvind Sood 4 MRCP, Dr Kanarath Balachandran 5 MD, Dr Raj Das 6 MD, Dr Shahid Junejo 7 FRCPI, Dr Nadeem Ahmed 1 MBChB, Dr Matthew M.Y. Lee 1 MRCP, Dr Aadil Shaukat 1 MRCP, Ms. Anna O'Donnell 1 BN, Mr Julian Nam 8 MSc, Professor Andrew Briggs 8 DPhil, Dr Robert Henderson 9 DM FRCP, Dr Alex McConnachie 10 PhD, Professor Colin Berry 1,2 FRCP PhD on behalf of the FAMOUS-NSTEMI investigators.1-West of Scotland Heart and Lung Centre, Golden Jubilee National Hospital, Clydebank, UK; 2-BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, UK; 3-University Hospital Southampton Foundation Trust, Southampton, UK; 4-Hairmyres Hospital, East Kilbride, UK; 5-Royal Blackburn Hospital, Blackburn, UK; 6-Freeman Hospital, Newcastle, UK; 7-City Hospitals Sunderland Foundation Trust, Sunderland, UK; 8-Health Economics and Health Technology Assessment Unit, University of Glasgow, UK; 9-Trent Cardiac Centre, Nottingham University Hospitals, Nottingham, UK; 10-Robertson Centre for Biostatistics, University of Glasgow, UK.
AimWe assessed the management and outcomes of non-ST segment elevation myocardial infarction (NSTEMI) patients randomly assigned to fractional flow reserve (FFR)-guided management or angiography-guided standard care.Methods and ResultsWe conducted a prospective, multicentre, parallel group, 1:1 randomised, controlled trial in 350 NSTEMI patients with ≥1 coronary stenosis ≥30% of the lumen diameter assessed visually (threshold for FFR measurement) (NCT01764334). Enrolment took place in 6 UK hospitals from October 2011 – May 2013. FFR was disclosed to the operator in the FFR guided-group (n=176). FFR was measured but not disclosed in the angiography-guided group (n=174). FFR ≤0.80 was an indication for revascularisation by percutaneous coronary intervention (PCI) or coronary artery bypass surgery (CABG). The median (IQR) time from the index episode of myocardial ischaemia to angiography was 3 (2, 5) days. For the primary outcome, the proportion of patients treated initially by medical therapy was higher in the FFR-guided group than in the angiography-guided group (40 (22.7%) vs. 23 (13.2%), difference 9•5% (95% CI 1.4%, 17.7%), p=0.022). FFR disclosure resulted in a change in treatment between medical therapy, PCI or CABG in 38 (21.6%) patients (Figures 2 & 3). At 12 months, revascularisation remained lower in the FFR-guided group (79.0% vs. 86.8%, difference 7.8% (-0.2%, 15.8%), p=0.054). There were no statistically significant differences in health outcomes and quality of life between the groups (Figure 4).ConclusionIn NSTEMI patients, angiography-guided management was associated with higher rates of coronary revascularisation compared with FFR-guided management. A larger trial is necessary to assess health outcomes and cost effectiveness.
By Bernard De Bruyne, (Aalst, Belgium)See Presenter abstract
Open the presentationWatch the Webcast
Hot Line: Myocardial Infarction
© 2017 European Society of Cardiology. All rights reserved